Evidence map›Paper›PMID 34077269›Full record

SynthesisJCO global oncology2021

Systematic Review of Cancer Research Output From Africa, With Zambia as an Example.

Violet Kayamba, Wilbroad Mutale, Holly Cassell, Douglas Corbett Heimburger, Xiao-Ou Shu

Abstract readSystematic Review
In one paragraph

Synthesis in JCO global oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Clinicopathological Characteristics and Mutational Landscape ofCurrent issues in molecular biology · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Violet KayambaTropical Gastroenterology and Nutrition Group, Department of Internal Medicine, Lusaka, Zambia.ORCID 0000-0002-6521-2501
Wilbroad MutaleUniversity of Zambia School of Public Health, Lusaka, Zambia.ORCID 0000-0002-4891-6750
Holly CassellVanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, TN.
Douglas Corbett HeimburgerUniversity of Zambia School of Medicine, Lusaka, Zambia.ORCID 0000-0003-3551-9710
Xiao-Ou ShuVanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-0711-8314

Funding

UNZA-Vanderbilt Training Partnership for HIV-NCD Research (UVP-2)D43TW009744 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HEIMBURGER, DOUGLAS CORBETT, MUTALE, WILBROAD · 2015 to 2025
$3.2M
FIC NIH HHS D43 TW009744
6 · The paper itself

Abstract

purposeCancer occurrence is increasing in Africa, although research has lagged. The objective of this review was to analyze cancer research outputs from Africa, with a particular focus on Zambia.

methodsWe searched PubMed for published cancer-related articles from African countries. All articles reporting on cancer in Africa were considered. We conducted analyses to explore correlations between cancer research output and total population, gross domestic product, and new cancer cases recorded in 2020. For Zambia articles, we also analyzed cancer types and time trends.

resultsA total of 48,487 cancer-related publications from Africa were identified, with nearly half coming from Egypt (13,372; 28%) and South Africa (9,393; 19%). Cancer research output correlated significantly with country population (Spearman's correlation coefficient 0.74;

conclusionCancer research output from Africa is very low, with many of the publications concentrated in a few countries. There is an urgent need to invest in both human resources and infrastructure to increase cancer research output from African countries, particularly in less populous countries.

Indexed as

NeoplasmsEgyptHumansSeychellesSouth AfricaTunisiaZambia

Identifiers

PMID34077269
PMCPMC8459799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.